CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...